FDA Approves Pfizer’s RSV Shot for Older Adults
THURSDAY, June 1, 2023 (HealthDay News) — Older adults may have a second vaccine option for RSV following the U.S. Food and Drug Administration’s approval of a Pfizer vaccine on Wednesday. The other shot for adults 60 and up is made by GSK. It was approved May 3. Both shouldContinue Reading